Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic hiv-1 gag vaccine trial

HIGHLIGHTS

  • who: Jonathan Z. Li and colleagues from the States of America, Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, UnitedEditor: Barbara Ensoli, Istituto Superiore di Sanità, Italy have published the Article: Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial, in the Journal: (JOURNAL) of March/30,/2012
  • what: The aims of this analysis were to characterize study participants with initial virologic suppression, evaluate viral and immunologic correlates of such a response, and determine the durability of virologic . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?